Press release MHRA approves GLP –1 receptor agonist semaglutide to lessen threat of great heart issues in obese or overweight Grown ups Semaglutide is the 1st weight loss drug accepted in britain to be a preventative remedy for all those with established heart problems We aid eligible indiv